Literature DB >> 263315

Calcium-regulating hormones during the menstrual cycle.

R M Pitkin, W A Reynolds, G A Williams, G K Hargis.   

Abstract

Calcium metabolism during the menstrual cycle was studied in seven women from whom fasting blood samples were drawn daily or every other day throughout ovulatory cycles. Total calcium (Ca), ionic calcium (Ca++), magnesium (Mg), phosphorus (P), and immunoreactive parathyroid hormone (PTH) and calcitonin (CT) were measured. LH levels were used to date each cycle and progesterone levels were used to confirm ovulation. Plasma estradiol was measured in two of the subjects. In six subjects with cycle lengths of 27-31 days, PTH levels rose progressively through the follicular phase to a peak at or slightly before the LH surge, then fell progressively through the luteal phase; peak PTH levels were 30-35% above early follicular and late luteal values. CT levels were also highest at midcycle, but the CT pattern was somewhat more variable than that of PTH. Ca++ tended to fall until 3-4 days before ovulation and then to increase, while Ca, Mg, and P exhibited no particular pattern. One subject experienced a prolonged (44 day) ovulatory cycle characterized by three distinct PTH peaks, each of which coincided with elevations in plasma estradiol level. These results represent the first report of menstrual cyclicity in calcium-regulating hormones. The timing suggest an estrogen effect and it is hypothesized that estrogen inhibits PTH-induced bone resorption, lowering serum Ca++, which in turn provokes a compensatory PTH output. With the decline of the preovulatory estrogen peak, Ca++ levels rise and PTH secretion falls. Alternatively, it is possible that the primary action may be an estrogen-induced rise in CT release, causing hypocalcemia and consequent PTH output. Cyclic changes in PRL release or vitamin D metabolism might also be involved.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 263315     DOI: 10.1210/jcem-47-3-626

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  Transdermal hormonal therapy in perimenstrual migraine: why, when and how?

Authors:  Cristina Tassorelli; Rosaria Greco; Marta Allena; Erica Terreno; Rossella E Nappi
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Exercise-induced changes in urinary water and mineral output during the menstrual cycle.

Authors:  D N Prashad; P A Fletcher; M Cooper
Journal:  Br J Sports Med       Date:  1987-03       Impact factor: 13.800

3.  Calcitonin, estradiol, and hydroxyproline as parameters in the early diagnosis of involutional osteoporosis. The importance of the "second calcitonin phenomenon".

Authors:  L Ferrández; M Martín; M Fernández
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

4.  North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.

Authors:  Haeseong Park; Rui Qin; Thomas J Smith; Pamela J Atherton; Debra L Barton; Keren Sturtz; Shaker R Dakhil; Daniel M Anderson; Kathleen Flynn; Suneetha Puttabasavaiah; Nguyet Anh Le-Lindqwister; Gilbert D A Padula; Charles L Loprinzi
Journal:  Menopause       Date:  2015-06       Impact factor: 2.953

5.  Associations between blood metals and fecundity among women residing in New York State.

Authors:  Michael S Bloom; Germaine M Buck Louis; Rajeshwari Sundaram; Paul J Kostyniak; Jinesh Jain
Journal:  Reprod Toxicol       Date:  2010-10-08       Impact factor: 3.143

6.  Response of parathyroid hormone to exercise and bone mineral density in adolescent female athletes.

Authors:  H Takada; K Washino; T Hanai; H Iwata
Journal:  Environ Health Prev Med       Date:  1998-01       Impact factor: 3.674

7.  Calcitonin secretion in streak gonad syndrome (Turner's syndrome).

Authors:  J Zseli; P Bosze; F Szalay; J Szucs; C Horvath; E Kollin; M Szathmari; J Laszlo; I Hollo
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

8.  Osteoblast-activating peptide exhibits a specific distribution pattern in mouse ovary and may regulate ovarian steroids and local calcium levels.

Authors:  Ahmed E Noreldin; Mahmoud S Gewaily; Islam M Saadeldin; Mosleh M Abomughaid; Asmaa F Khafaga; Yaser H Elewa
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

9.  Changes in serum calcium, magnesium and inorganic phosphorus levels during different phases of the menstrual cycle.

Authors:  Puja Dullo; Neeraj Vedi
Journal:  J Hum Reprod Sci       Date:  2008-07

10.  Urinary biochemical markers for bone resorption during the menstrual cycle.

Authors:  I Gorai; O Chaki; M Nakayama; H Minaguchi
Journal:  Calcif Tissue Int       Date:  1995-08       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.